Citation

Krupp L, Patel Y, Bhise V. Current Clinical Neurology 2011; 40: 157-177.

Copyright

(Copyright © 2011)

DOI

10.1007/978-1-60327-860-7_8

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; prognosis; Fatigue; incidence; Cognition; insomnia; depression; psychosis; suicide attempt; Prognosis; risk assessment; mood disorder; neuroimaging; pathogenesis; fatigue; article; disease association; differential diagnosis; clinical feature; cognitive defect; fluoxetine; priority journal; headache; nuclear magnetic resonance imaging; steroid; drug safety; placebo; child health care; carbamazepine; drug efficacy; drug tolerability; leukopenia; drug withdrawal; drug megadose; onset age; fever; hypertension; relapse; flu like syndrome; myalgia; plasmapheresis; methylprednisolone; multiple sclerosis; leukocytosis; laboratory test; baclofen; hyperglycemia; motor dysfunction; trigeminus neuralgia; arthritis; beta1a interferon; glatiramer; drug dose titration; injection site reaction; cyclophosphamide; enteropathy; oxybutynin; interferon beta serine; prednisone; donepezil; natalizumab; spasticity; disorders of mitochondrial functions; morning dosage; urinary dysfunction; immunoglobulin; leukodystrophy; drug dose escalation; solifenacin; tolterodine; evoked visual response; brain vasculitis; acute disseminated encephalomyelitis; brain lymphoma; Initial demyelinating event; myelooptic neuropathy; Optic neuritis